Literature DB >> 7216442

Nature of the cross-protective antigen in subcellular vaccines of Streptococcus pneumoniae.

C C Au, T K Eisenstein.   

Abstract

Studies have been carried out to investigate the nature of the antigen present in subcellular extracts of a rough strain of Streptococcus pneumoniae A662b which has been shown to confer protection in mice against challenge with smooth, virulent organisms of the homologous and heterologous serotypes. The finding that whole, heat-killed cells were also capable of immunizing mice against challenge with organisms of heterologous serotypes suggests that the immunogen is present on the surface of the rough pneumococcal cell. Ribosomes purified by sucrose gradient centrifugation were not protective, but material recovered in the pellet retained activity. Subcellular extracts prepared from spheroplasts with a partial absence of cell wall showed decreased protective capacity, and extracts prepared from wall-deficient protoplasts were not protective. Crude cell walls evidenced cross-serotype protection, but purified walls did not protect. These results are interpreted as suggesting that the active moiety in the subcellular vaccine is present on the surface of rough pneumococci and is either a wall antigen that must be part of a larger macromolecular complex to be immunogenic, or a substance associated with the cell wall that is present in crude, but not purified, cell wall fractions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216442      PMCID: PMC351765          DOI: 10.1128/iai.31.1.160-168.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Biological properties of an immunogenic pneumococcal subcellular preparation.

Authors:  H C Thompson; T K Eisenstein
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

2.  Membrane location of a deoxyribonuclease implicated in the genetic transformation of Diplococcus pneumoniae.

Authors:  S Lacks; M Neuberger
Journal:  J Bacteriol       Date:  1975-12       Impact factor: 3.490

3.  Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction.

Authors:  C L Swendsen; W Johnson
Journal:  Infect Immun       Date:  1976-08       Impact factor: 3.441

4.  Integration efficiency and genetic recombination in pneumococcal transformation.

Authors:  S Lacks
Journal:  Genetics       Date:  1966-01       Impact factor: 4.562

5.  Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme.

Authors:  J L Mosser; A Tomasz
Journal:  J Biol Chem       Date:  1970-01-25       Impact factor: 5.157

6.  Immunogenicity of ribosomes from enzymatically lysed Streptococcus pyogenes.

Authors:  B A Green; W Johnson
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

7.  Pneumococcal Forssman antigen. A choline-containing lipoteichoic acid.

Authors:  E B Briles; A Tomasz
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

8.  Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

Authors:  W O Schalla; W Johnson
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

9.  Pneumococcal C-substance, a ribitol teichoic acid containing choline phosphate.

Authors:  D E Brundish; J Baddiley
Journal:  Biochem J       Date:  1968-12       Impact factor: 3.857

10.  Protection against pneumococcal infection by a ribosomal preparation.

Authors:  H C Thompson; I S Snyder
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

View more
  14 in total

1.  Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.

Authors:  S C Szu; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.

Authors:  J Yother; C Forman; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

4.  Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; M Crain
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

5.  Ribonuclease-sensitive ribosomal vaccines.

Authors:  R Gonggrijp; A C Antonissen; J F van den Bosch; C P van Boven
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

6.  Epidemiological studies of Streptococcus pneumoniae in infants: development of antibody to phosphocholine.

Authors:  B M Gray; H C Dillon; D E Briles
Journal:  J Clin Microbiol       Date:  1983-11       Impact factor: 5.948

7.  A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.

Authors:  E J Brown; S W Hosea; C H Hammer; C G Burch; M M Frank
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

8.  Antibacterial resistance, macrophage influx, and activation induced by bacterial rRNA with dimethyldioctadecylammonium bromide.

Authors:  R Gonggrijp; W J Mullers; H F Dullens; C P van Boven
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.

Authors:  Richard Malley; Amit Srivastava; Marc Lipsitch; Claudette M Thompson; Claire Watkins; Arthur Tzianabos; Porter W Anderson
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

10.  Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.

Authors:  S C Szu; S Clarke; J B Robbins
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.